Literature DB >> 21785992

Chronic diarrhea and malabsorption due to hypogammaglobulinemia: a report on twelve patients.

Uday C Ghoshal1, Amit Goel, Ujjala Ghoshal, Manoj Jain, Asha Misra, Gourdas Choudhuri.   

Abstract

Hypogammaglobulinemic sprue (HGS), which may predispose to infection, is uncommon. Twelve patients (all men; median age 29 years, 15-50) with HGS (4%) of 296 with chronic small bowel diarrhea and malabsorption syndrome (MAS) during a 10-year period were analyzed. Treatment of HGS was delayed due to misdiagnosis as intestinal tuberculosis (n = 7) and diarrhea-predominant irritable bowel syndrome (n = 1). All had diarrhea and weight loss (median loss 12 Kg). Associated conditions were clubbing, bronchiectasis, and seizure (2 patients each), and hypothyroidism (n = 1). Laboratory parameters were urinary D-xylose median 0.46 g/5 g/5 h (range 0.2-1.6; normal ≥ 1), fecal fat 11.9 g/day (3.8-16.7; normal ≤ 7 g), serum IgA, IgG, and IgM: 23.5 mg/dL (17-114; normal 90-450), 584 mg/dL (145-1051; normal 800-1800), and 23 (0-40.3; normal 60-280). IgA, IgG, and IgM were low in 10, 10, and 11, respectively. Duodenal biopsy was normal in 6 patients and showed partial villous atrophy in 6 and nodular lymphoid hyperplasia in two. Associated infections were giardiasis (n = 1), disseminated strongyloidiasis (1), small intestinal bacterial overgrowth (3), septicemia (2), and septic arthritis (1). Two patients died of sepsis, five are well on immunoglobulin and specific anti-infective treatment, and five are lost to follow up. Approximately 4% patients with MAS have hypogammaglobulinemia, which is often associated with infection and is diagnosed late.

Entities:  

Mesh:

Year:  2011        PMID: 21785992     DOI: 10.1007/s12664-011-0111-y

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  13 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  Practice parameter for the diagnosis and management of primary immunodeficiency.

Authors:  Francisco A Bonilla; I Leonard Bernstein; David A Khan; Zuhair K Ballas; Javier Chinen; Michael M Frank; Lisa J Kobrynski; Arnold I Levinson; Bruce Mazer; Robert P Nelson; Jordan S Orange; John M Routes; William T Shearer; Ricardo U Sorensen
Journal:  Ann Allergy Asthma Immunol       Date:  2005-05       Impact factor: 6.347

Review 3.  Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature.

Authors:  P E Tarr; M C Sneller; L J Mechanic; A Economides; C M Eger; W Strober; C Cunningham-Rundles; D R Lucey
Journal:  Medicine (Baltimore)       Date:  2001-03       Impact factor: 1.889

4.  Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes.

Authors:  C Pignata; G Budillon; G Monaco; E Nani; R Cuomo; G Parrilli; F Ciccimarra
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

5.  Etiological spectrum of sporadic malabsorption syndrome in northern Indian adults at a tertiary hospital.

Authors:  Piyush Ranjan; Uday C Ghoshal; Rakesh Aggarwal; Rakesh Pandey; Asha Misra; Sita Naik; Subhash R Naik
Journal:  Indian J Gastroenterol       Date:  2004 May-Jun

6.  Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia.

Authors:  K Washington; T T Stenzel; R H Buckley; M R Gottfried
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

7.  Common variable immunodeficiency syndrome and nodular lymphoid hyperplasia in the small intestine.

Authors:  C Bästlein; R Burlefinger; E Holzberg; C Voeth; M Garbrecht; R Ottenjann
Journal:  Endoscopy       Date:  1988-09       Impact factor: 10.093

8.  Intravenous immune globulin therapy. Treatment of a patient with severe immunodeficiency, chronic malabsorption, and fulminant septicemia.

Authors:  E B Gonzalez; B G Guernsey; N B Ingrim; Y Ichikawa; J C Daniels
Journal:  Arch Intern Med       Date:  1985-05

9.  Hypogammaglobulinaemic sprue in tropics: Report of an Indian patient.

Authors:  S K Mehta; S R Naik; S Krishnan; C K Nain; S Sehgal
Journal:  J Trop Med Hyg       Date:  1978-07

10.  Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics.

Authors:  Ujjala Ghoshal; Uday C Ghoshal; Piyush Ranjan; Subhash R Naik; Archana Ayyagari
Journal:  BMC Gastroenterol       Date:  2003-05-24       Impact factor: 3.067

View more
  6 in total

1.  Good Syndrome, a rare cause of refractory chronic diarrhea and recurrent pneumonia in a Chinese patient after thymectomy.

Authors:  Junyan Qu; Xiaoju Lü; Qin Gao; Yan Zhang
Journal:  Clin Vaccine Immunol       Date:  2013-05-22

2.  Rationale of using multiplex polymerase chain reaction (PCR) panels for etiological diagnosis of infective diarrhea in the tropics.

Authors:  Ujjala Ghoshal; Nidhi Tejan
Journal:  Indian J Gastroenterol       Date:  2018-09

3.  Association between common variable immunodeficiency and collagenous infiltrative disorders of the gastrointestinal tract: A series of four patients.

Authors:  Rohan Mandaliya; Ashlie L Burkart; Anthony J DiMarino; Satish Rattan; Sidney Cohen
Journal:  Indian J Gastroenterol       Date:  2016-04-07

4.  Hypogammaglobulinemia-associated gastrointestinal disease--a case series.

Authors:  Laxmikant Desai; Reuben Thomas Kurien; Ebby George Simon; Amit Kumar Dutta; Anjilivelil Joseph Joseph; Sudipta Dhar Chowdhury
Journal:  Indian J Gastroenterol       Date:  2014-10-30

5.  Giardia: both a harmless commensal and a devastating pathogen.

Authors:  Herbert L DuPont
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

Review 6.  Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.

Authors:  David Avelar Rodriguez; Paul MacDaragh Ryan; Erick Manuel Toro Monjaraz; Jaime Alfonso Ramirez Mayans; Eamonn Martin Quigley
Journal:  Front Pediatr       Date:  2019-09-04       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.